Metraipolis › archive › dc_1f88fb01ca0d
Potential Anti-Cancer Drug 6RK73 Suppresses Ovarian Cancer Growth by Inactivating the AKT1/Sp1 Induced c-Myc Signaling Pathway — Europe PMC PMID:41584043
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41584043
- DOI
- 10.7150/jca.113511
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T03:43:42.332Z
- SHA-256 of the archived text
e79822ea894718e39800483b58738ba26c6c6b2fca4cbe1a8fb7e846d932eb06- Stable URL of this page
https://metraipolis.com/documento/dc_1f88fb01ca0d
How to cite
Potential Anti-Cancer Drug 6RK73 Suppresses Ovarian Cancer Growth by Inactivating the AKT1/Sp1 Induced c-Myc Signaling Pathway — Europe PMC PMID:41584043 — Europe PMC (en), https://europepmc.org/article/MED/41584043 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1f88fb01ca0d (Metraipolis archive dc_1f88fb01ca0d, sha256 e79822ea894718e39800483b58738ba26c6c6b2fca4cbe1a8fb7e846d932eb06)
BibTeX
@misc{dc1f88fb01ca0d,
title = {Potential Anti-Cancer Drug 6RK73 Suppresses Ovarian Cancer Growth by Inactivating the AKT1/Sp1 Induced c-Myc Signaling Pathway — Europe PMC PMID:41584043},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41584043},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1f88fb01ca0d; sha256 e79822ea894718e39800483b58738ba26c6c6b2fca4cbe1a8fb7e846d932eb06},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41584043. Agents can read the archived copy with the MCP tool read_document.